These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34697276)

  • 1. Safety/Efficacy of Prucalopride in Korean Patients with Chronic Constipation: Post-marketing Surveillance.
    Yeon SE; Kim SY; Chung WC; Jeon SW; Park SJ; Choi CH; Choi MG
    Korean J Gastroenterol; 2021 Oct; 78(4):219-226. PubMed ID: 34697276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety analysis of prucalopride in refractory chronic constipation cases in a tertiary care hospital in Eastern India: A randomized, single-blind, placebo-controlled study.
    Dehury S; Mohapatra S; Das HS; Goutam S; Kaushik C
    Indian J Pharmacol; 2023; 55(1):6-13. PubMed ID: 36960515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A placebo-controlled trial of prucalopride for severe chronic constipation.
    Camilleri M; Kerstens R; Rykx A; Vandeplassche L
    N Engl J Med; 2008 May; 358(22):2344-54. PubMed ID: 18509121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.
    Tack J; van Outryve M; Beyens G; Kerstens R; Vandeplassche L
    Gut; 2009 Mar; 58(3):357-65. PubMed ID: 18987031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prucalopride on symptoms of chronic constipation.
    Tack J; Stanghellini V; Dubois D; Joseph A; Vandeplassche L; Kerstens R
    Neurogastroenterol Motil; 2014 Jan; 26(1):21-7. PubMed ID: 24106924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.
    Quigley EM; Vandeplassche L; Kerstens R; Ausma J
    Aliment Pharmacol Ther; 2009 Feb; 29(3):315-28. PubMed ID: 19035970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial.
    Coremans G; Kerstens R; De Pauw M; Stevens M
    Digestion; 2003; 67(1-2):82-9. PubMed ID: 12743445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation.
    Sloots CE; Rykx A; Cools M; Kerstens R; De Pauw M
    Dig Dis Sci; 2010 Oct; 55(10):2912-21. PubMed ID: 20428949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prucalopride for the treatment of women with chronic constipation in whom standard laxative regimens have failed to provide adequate relief.
    Pennant M; Orlando R; Barton P; Bayliss S; Routh K; Meads C
    Health Technol Assess; 2011 May; 15 Suppl 1():43-50. PubMed ID: 21609652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of electroacupuncture versus prucalopride for severe chronic constipation: protocol of a multi-centre, non-inferiority, randomised controlled trial.
    Liu B; Wang Y; Wu J; Mo Q; Wang W; He L; Yan S; Liu Z
    BMC Complement Altern Med; 2014 Jul; 14():260. PubMed ID: 25055821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis.
    Luthra P; Camilleri M; Burr NE; Quigley EMM; Black CJ; Ford AC
    Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):831-844. PubMed ID: 31474542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of prucalopride in adults with chronic idiopathic constipation.
    Vijayvargiya P; Camilleri M
    Expert Rev Clin Pharmacol; 2019 Jul; 12(7):579-589. PubMed ID: 31096799
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term outcome of prucalopride for chronic constipation: a single-centre study.
    Dhruva Rao PK; Lewis M; Peiris SP; Shah PR; Haray PN
    Colorectal Dis; 2015 Dec; 17(12):1079-84. PubMed ID: 25951504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study.
    Ke M; Zou D; Yuan Y; Li Y; Lin L; Hao J; Hou X; Kim HJ
    Neurogastroenterol Motil; 2012 Nov; 24(11):999-e541. PubMed ID: 22882724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation -- a comparison in a controlled environment.
    Cinca R; Chera D; Gruss HJ; Halphen M
    Aliment Pharmacol Ther; 2013 May; 37(9):876-86. PubMed ID: 23480216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral prucalopride in children with functional constipation.
    Winter HS; Di Lorenzo C; Benninga MA; Gilger MA; Kearns GL; Hyman PE; Vandeplassche L; Ausma J; Hoppenbrouwers M
    J Pediatr Gastroenterol Nutr; 2013 Aug; 57(2):197-203. PubMed ID: 23535761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prucalopride: a review of its use in the management of chronic constipation.
    Keating GM
    Drugs; 2013 Nov; 73(17):1935-50. PubMed ID: 24194435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prucalopride: A Review in Chronic Idiopathic Constipation.
    Garnock-Jones KP
    Drugs; 2016 Jan; 76(1):99-110. PubMed ID: 26628294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of oral prucalopride in women with chronic constipation in whom laxatives have failed: an integrated analysis.
    Tack J; Quigley E; Camilleri M; Vandeplassche L; Kerstens R
    United European Gastroenterol J; 2013 Feb; 1(1):48-59. PubMed ID: 24917940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation.
    Yiannakou Y; Piessevaux H; Bouchoucha M; Schiefke I; Filip R; Gabalec L; Dina I; Stephenson D; Kerstens R; Etherson K; Levine A
    Am J Gastroenterol; 2015 May; 110(5):741-8. PubMed ID: 25869393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.